You are here

Article info

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Epidemiology
Research
Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study

Authors

  1. Correspondence to Dr Vincent Bauchau; vincent.g.bauchau{at}gsk.com
View Full Text

Citation

Nazareth I, Tavares F, Rosillon D, et al
Safety of AS03-adjuvanted split-virion H1N1 (2009) pandemic influenza vaccine: a prospective cohort study
BMJ Open 2013;3:e001912. doi: 10.1136/bmjopen-2012-001912

Publication history

  • Received October 4, 2012
  • Revised December 21, 2012
  • Accepted January 9, 2013
  • First published February 5, 2013.
Online issue publication 
October 25, 2017
Previous versions
Review history

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.